LAVA Reports Surpassing Minimum Requirement in Tender Offer and Plans to Withdraw from Nasdaq

Written by Emily J. Thompson, Senior Investment Analyst

LVTX%

Source: Newsfilter

Updated: Nov 13 2025

0mins

Source: Newsfilter

Tender Offer Success: LAVA Therapeutics announced that approximately 87% of its outstanding common shares were validly tendered in the offer from XOMA Royalty, satisfying the minimum tender condition for the acquisition.
Subsequent Offering Period: A subsequent offering period has begun for LAVA shareholders who have not yet tendered their shares, which will end on November 20, 2025, with shares expected to be suspended from trading on Nasdaq shortly thereafter.
Voluntary Delisting: LAVA has notified Nasdaq of its intention to voluntarily delist its common shares, contingent upon the completion of the acquisition by XOMA Royalty.
Forward-Looking Statements: The press release includes cautionary notes regarding forward-looking statements, highlighting various risks and uncertainties that could affect the completion of the tender offer and LAVA's business operations.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

LAVA Reports Surpassing Minimum Requirement in Tender Offer and Plans to Withdraw from Nasdaq

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Trump Denies Considering JPMorgan's Dimon for Fed Chair Position

General Motors Increases Dividend by 25% and Launches $6 Billion Buyback Program

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch